% Receiving chemotherapy during | |||||
Study | Patients, N | Type of cancer | Inclusion criteria | Last 30 DOL | Last 14 DOL |
Rautakorpi et al25 | 38 982 | All | Any | 16 | 7.2 |
Falchook et al32 | 12 765 | Lung | Patients<65 years | 12.6 | |
Ersek et al42 | 847 | NSCLC | Any | 30.6 | |
Wright et al14 | 1146 | All | Any | 6.5 | |
Bekelman et al49 | 389 073 | All | USA | 10.6 | |
The Netherlands | 10.6 | ||||
Belgium | 12.7 | ||||
Canada | 8.8 | ||||
UK | NR | ||||
Germany | 10.5 | ||||
Norway | 4.8 | ||||
Sano and Fushimi45 | 26 012 | All | Palliative care consultation | 1.7 | |
SOC | 4.0 | ||||
Parekh et al51 | 242 | NSCLC | 2009–10 Prepalliative care | 17.0 | |
2003–14 Postpalliative care | 7.0 | ||||
Pacetti et al39 | 2164 | All | Any | 24.3 | |
Wang et al52 | 82 242 | All | 2005 | 4.4 | |
2009 | 4.0 | ||||
Choi et al30 | 263 | All | 2002 | 14.0 | 3.5 |
2012 | 42.7 | 23.8 | |||
Cheung et al31 | 107 253 | All | Any | 3.6 | |
Lee et al38 | 2345 | All | 2000 | 25.7 | |
2005 | 32.7 | ||||
2010 | 44.2 | ||||
Kok et al27 | 266 | NSCLC | 2008–2009 | 5.0 | |
2011–2012 | 1.0 | ||||
Zhang et al63 | 118 | NSCLC | Any | 27 | |
Adam et al33 | 120 | All | Any | 11.7 | 7.6 |
Sesé et al35 | 94 | Lung | Any | 55 | 22 |
Amano et al58 | 266 | All | Early palliative care | 17 | |
SOC | 23 | ||||
Greer et al29 | 151 | NSCLC | SOC | 43.3 | 23.9 |
Early palliative care | 30.0 | 13.6 | |||
Mack et al46 | 1231 | NSCLC and colorectal | Any | 16.0 | |
Näppä et al40 | 374 | All | Any | 23 | |
Gonsalves et al44 | 200 | All | 2002 | 5 | |
2008 | 18 | ||||
Ho et al37 | 227 161 | All | 1993 | 2.02 | |
2003 | 2.9 | ||||
Andreis et al59 | 102 | All | Any | 16 | 6 |
Warren et al53 | 21 633 | All | Patients with OS <6 months | 14.8 | 9 |
Patients with OS >6 months | 10.2 | 6.4 | |||
Keating et al47 | 5826 | NSCLC and colorectal | VHA cohort | 4.6 | |
SEER cohort | 7.5 | ||||
Kao et al62 | 747 | All | Any | 18 | 8.0 |
Hashimoto et al55 | 255 | All | Any | 12.6 | 3.10 |
Tang et al28 | 242 530 | All | Trend 2000–2006 | 16.2 | |
Barbera et al34 | 5855 | All | Any | 4.6 | |
Earle et al11 | 215 484 | All | 1993 | 9.70 | |
1999 | 11.6 | ||||
Temel et al36 | 46 | NSCLC | Integrated palliative care | 40 | 23 |
Yun et al54 | 3750 | All | Any | 30.9 | 22.5 |
Murillo and Koeller41 | 417 | NSCLC | Any | 43 | 20.0 |
Earle et al16 | 28 777 | All | 1993 | 13.8 | |
1996 | 18.5 | ||||
Giorgi et al57 | 193 | All | Any | 33 | |
Emanuel et al48 | 7919 | All | Massachusetts | 9 | |
California | 9 | ||||
Aragon-Ching etal56 | 144 | All | Any | 26 |
NR, not reported; NSCLC, non-small cell lung cancer; SEER, Surveillance, Epidemiology and End Results; SOC, standard of care; VHA, Veterans Health Administration.